A deficiency in DENR leads to decreased JAK2 translation and impairs JAK-STAT signaling, thus reducing PD-L1 expression in tumor cells and repressing tumor growth by enhancing the anti-tumor killing activity of CD8+ T cells in the tumor microenvironments. The gene discussed is JAK2; the disease is neoplasm.